HHS Issues Guidance on High-flow Nasal Cannulation in COVID-19 Patients

Published: 11/13/2020

  • Department of Health and Human Services
Relevant To:
  • Critical Access Hospitals,
  • Hospitals

The U.S. Department of Health and Human Services (HHS) has issued guidance on high-flow nasal cannulation as a non-invasive resuscitation therapy for COVID-19 patients. According to HHS, high-flow nasal cannula (HFNC) therapy is less invasive than mechanical ventilation and has shown clinical utility in treating severe and critical COVID-19 patients.  There are several considerations for healthcare providers exploring this type of therapy for COVID-19 infections:

  • Ensuring careful patient s

Sign Up for Free Trial